(Q92622047)
Statements
A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC) (English)
Mitchell L Ramsey
Janet Nuttall
Phil A Hart
TACTIC Investigative Team